Neurodevelopmental outcome following exposure to sedative and analgesic drugs for complex cardiac surgery in infancy*
Authors:
- Ari R. JoffeAJAri R. Joffe
- the Western Canadian Complex Pediatric Therapies Follow‐up GroupTGthe Western Canadian Complex Pediatric Therapies Follow‐up Group
- 21 April 2011
- journal article
- Published by Wiley in Pediatric Anesthesia
- Vol. 21 (9) , 932-941
Abstract
Summary: Objectives/Aim: To determine whether sedation/analgesia drugs used before, during, and after infant cardiac surgery are associated with neurodevelopmental outcome.Background: Animal models suggest detrimental effects of anesthetic drugs on the developing brain. Whether these results can be extrapolated to human neonates is unclear.Methods/Materials: This is a prospective follow‐up project conducted in Western Canada. In all infants ≤6 weeks of age having surgery for congenital heart disease between April 2003 and December 2006, demographic and perioperative variables were collected prospectively. Sedation/analgesia variables were collected retrospectively. For each drug class (inhalationals, opioids, benzodiazepines, ketamine, and chloral hydrate), we calculated the cumulative dose received during hospitalization, average dose received per day, and cumulative number of days the patient received the drug. The outcomes at 18–24 months were as follows: General Adaptive Composite and motor scaled scores of the Adaptive Behavior Assessment System, significant mental, motor, and vocabulary delay. Multivariable logistic and linear regression was used to analyze the data.Results: One hundred and thirty‐five neonates underwent open heart surgery; 19 died, 16 had chromosomal abnormality, and five were lost to follow up, leaving 95 survivors for analysis. Multiple linear regression analysis found no evidence of an association between sedation/analgesia variables and ABAS‐GAC score or motor scale score. Multiple logistic regression analysis found no evidence of an association between sedation/analgesia variables and significant mental, motor, or vocabulary delay.Conclusion: We found no evidence of an association between dose and duration of sedation/analgesia drugs during the operative and perioperative period and adverse neurodevelopmental outcomes.Keywords
This publication has 32 references indexed in Scilit:
- Tumor necrosis factor-α triggers a cytokine cascade yielding postoperative cognitive declineProceedings of the National Academy of Sciences, 2010
- A Retrospective Cohort Study of the Association of Anesthesia and Hernia Repair Surgery With Behavioral and Developmental Disorders in Young ChildrenJournal of Neurosurgical Anesthesiology, 2009
- Early Exposure to Anesthesia and Learning Disabilities in a Population-based Birth CohortAnesthesiology, 2009
- Anesthetic-Related Neurotoxicity in the Developing Infant: Of Mice, Rats, Monkeys and, Possibly, HumansAnesthesia & Analgesia, 2008
- Two-year general and neurodevelopmental outcome after neonatal complex cardiac surgery in patients with deletion 22q11.2: A comparative studyThe Journal of Thoracic and Cardiovascular Surgery, 2007
- The Concentration-Effect Relationship of the Respiratory Depressant Effects of Alfentanil and FentanylAnesthesia & Analgesia, 2001
- Dose Comparison of Remifentanil and Alfentanil for Loss of ConsciousnessAnesthesiology, 1997
- The Pharmacology of Sevoflurane in Infants and ChildrenAnesthesiology, 1994
- Minimum Alveolar Concentration of Desflurane and Hemodynamic Responses in Neonates, Infants, and ChildrenAnesthesiology, 1991
- Electroencephalographic Quantitation of Opioid EffectAnesthesiology, 1991